Average Co-Inventor Count = 4.00
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roussel Uclaf (4 from 854 patents)
2. Aventis Pharma S.a. (3 from 377 patents)
3. Hoechst Marion Roussel (1 from 236 patents)
8 patents:
1. 8709426 - Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
2. 7294712 - Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
3. 6596536 - Nucleotide sequences coding for variable regions of the alpha chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
4. 6114516 - Nucleotide sequences coding for variable regions of the .alpha.chains of
5. 5830758 - Isolated V.beta. TCR antibodies
6. 5817511 - Nucleotide sequence coding for variable regions of the .alpha. chains of
7. 5798231 - Nucleotide sequences for .alpha. chain variable regions in human
8. 5700907 - Nucleotide sequences coding for variable regions of .beta. chains of